Shroyer Duane B MD Birmingham, AL - 35205

Shroyer Duane B MD is categorized under Internal Medicine Doctors in Birmingham, AL and active since 2001.

Shroyer Duane B MD was established in 2001, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Duane Shroyer at the company’s single location by writing to 833 Saint Vincents Drive # 502, Birmingham, Alabama AL 35205 or by phoning (205) 933-4433. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Shroyer Duane B MD
Contact Person: Duane Shroyer
Address: 833 Saint Vincents Drive # 502, Birmingham, Alabama 35205
Phone Number: (205) 933-4433
Website Address: southviewmedical.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2001
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Shroyer Duane B MD was started in 2001 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Duane Shroyer for inquiries that concern Shroyer Duane B MD by calling the company number (205) 933-4433, as your correspondence is most welcome. Additionally, the physical location of the single location of Shroyer Duane B MD can be found at the coordinates 33.50859,-86.78856 as well as the street address 833 Saint Vincents Drive # 502 in Birmingham, Alabama 35205.

For its online presence, you may visit Shroyer Duane B MD’s website at southviewmedical.com and engage with its social media outlets through on Twitter and on Facebook.